BeckettAHTriggsEJ. Enzyme induction in man caused by smoking. Nature1967; 216: 587.
2.
HuntSNJuskoWJYurchakAM. Effect of smoking on theophylline disposition. Clin Pharmacol Ther1976; 19: 546–51.
3.
PowellJRThiercelinJFVozehSSansomLRiegelmanS. The influence of cigarette smoking and sex on theophylline disposition. Am Rev Respir Dis1977; 116: 17–24.
4.
VaughnDPBeckettAHRobbieDS. The influence of smoking on the inter-subject variation in pentazocine elimination. Br J Clin Pharmacol1976; 3: 279–83.
5.
PantuckEJKuntzmanRConneyAH. Decreased concentration of phenacetin in plasma of cigarette smokers. Science1972; 175: 1248–50.
6.
PantuckEJHsiaoKCMaggioANakamuraKKuntzmanRConneyAH. Effect of cigarette smoking on phenacetin metabolism. Clin Pharmacol Ther1973; 15: 9–17.
7.
PerelJMHurvieMJKanzlerMB. Pharmacodynamics of imipramine in depressed patients. Psychopharmacol Bull1975; 11: 16–18.
8.
PerelJMShostakMGannEKantorSLGlassmanAH. Pharmacodynamics of imipramine and clinical outcome in depressed patients. In: GottschalkLAMerlisS, eds. Pharmacokinetics of psychoactive drugs. New York: Spectrum Publications, 1976: 229–41.
9.
VestelRENorrisAHTobinJDCohenBHShockNWAndesR. Antipyrine metabolism in man: Influence of age, alcohol, caffeine, and smoking. Clin Pharmacol Ther1975; 18: 425–32.
10.
CrowJWPedrolainMDBodnerFShoemanDWAzarnoffDL. Glutethimide and 4-OH glutethimide. Pharmacokinetics and effect on human performance in smokers and nonsmokers. Clin Pharmacol Ther1977; 22: 458–64.
11.
Boston Collaborative Drug Surveillance Program. Clinical depression of the central nervous system due to diazepam and chlordiazepoxide in relation to cigarette smoking and age. N Engl J Med1973; 288: 277–80.
12.
PfeiferHJGreenblattDJ. Decreased theophylline toxicity among cigarette smokers: A report from the Boston Collaborative Drug Surveillance Program. Chest1978; 73: 455–9.
13.
Boston Collaborative Drug Surveillance Program. Decreased clinical efficacy of propoxyphene in cigarette smokers. Clin Pharmacol Ther1973; 14: 259–63.
14.
Karri-SzantoMPomeroyJR. Atmospheric pollution and pentazocine metabolism. Lancet1971; 1: 947–9.
15.
SwettC. Drowsiness due to chlorpromazine in relation to cigarette smoking. Arch Gen Psychiatry1974; 31: 211–3.
16.
JuskoWJ. Role of tobacco smoking on pharmacokinetics. J Pharmacokinet Biopharm1978; 6: 7–39.
17.
JuskoWJ. Influence of cigarette smoking on drug metabolism in man. Drug Metab Rev1979; 9: 221–36.
18.
WeitmanMSchebleRJohnsonKGAbbeyH. Correlations among use of drugs. Am J Public Health1972; 62: 156–60.
19.
SeltzerCC. Constitution and heredity in relation to tobacco smoking. Ann NY Acad Sci1967; 142: 322–30.
20.
AdlerTKFujimotoJMWayELBakerEM. The metabolic fate of codeine in man. J Pharmacol Exp Ther1955; 114: 251–62.
21.
WayELAdlerTK. The biological disposition of morphine and its surrogates—2. Bull WHO1962; 26: 51–66.
22.
FindlayJWAButzRFWelchRM. Codeine kinetics as determined by radioimmunoassay. Clin Pharmacol Ther1977; 22: 439–46.
23.
FindlayJWAJonesECButzRFWelchRM. Plasma codeine and morphine concentrations after therapeutic oral doses of codeine-containing analgesics. Clin Pharmacol Ther1978; 24: 60–8.
24.
RogersJFFindlayJWAHullJH. Codeine disposition in smokers and nonsmokers. Clin Pharmacol Ther1982; 32: 218–27.
25.
FindlayJWAButzRFJonesEC. Relationships between immunogen structure and antisera specificity in the narcotic alkaloid series. Clin Chem1981; 27: 1524–35.
26.
FindlayJWAButzRFWelchRM. A codeine radioimmunoassay exhibiting insignificant cross-reactivity with morphine. Life Sci1976; 19: 389–94.
27.
FindlayJWAButzRFWelchRM. Specific radioimmunoassays for codeine and morphine. Metabolism of codeine to morphine in the rat. Res Commun Chem Pathol Pharmacol1977; 17: 595–603.
28.
Statistical analysis system (SAS) user's guide. Cary, NC: SAS Institute Inc., 1979. (Available through Triangle Universities Computer Center, Research Triangle Park, NC).
29.
MarquardtDW. An algorithm for least-squares estimation of nonlinear parameters. J Soc Ind Appl Math1963; 11: 431–41.
30.
YamaokaKNakaganaTUnoT. Application of Akaiki's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm1978; 6: 165–75.
31.
HaynesJD. Statistical simulation study of new proposed uniformity requirement for bioequivalency studies. J Pharm Sci1981; 70: 673–5.
32.
WilkinsonGRShandDG. A physiological approach to hepatic drug clearance. Clin Pharmacol Ther1975; 18: 377–90.
33.
RowlandM. Influence of route of administration on drug availability. J Pharm Sci1972; 61: 70–4.
34.
KornhauserDMWoodAJJVestalREWilkinsonGR. Biological determinants of propranolol disposition in man. Clin Pharmacol Ther1978; 23: 165–74.
35.
HuetPMLelorierJ. Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics. Clin Pharmacol Ther1980; 28: 208–15.
36.
BeaverWTWallensteinSLRogersAHoudeRW. Analgesic studies of codeine and oxycodone in patients with cancer. 1. Comparison of oral with intramuscular codeine and of oral with intramuscular oxycodone. J Pharmacol Exp Ther1978; 307: 92–100.